Abstract:Background: Patients with severe novel coronavirus disease (COVID-19) can likely develop comorbidities, which can lead to irreversible organ damage and, eventually, death. However, early indicators of disease progression remain unclear. This study aimed to identify early indicators of disease progression to provide a basis for improved prognostic prediction and disease management. Methods: We examined 53 recovered adult COVID-19 patients who were treated at Shanghai Public Health Clinical Center between January 20, 2020, and February 20, 2020. The patients were categorized into the following four groups according to their condition at admission: mild condition (n = 3), moderate (n = 41), severe (n = 7), and critical (n = 2). They were also categorized according to disease progression as mild or moderate conditions that remained stable (n = 26), moderate disease that progressed to severe condition (n = 18), and continuously severe or critical (n = 9). We then focused on investigating the differences in the epidemiological and laboratory indicators between remained stable cases and progressed to severe condition cases. Results: Mild or moderate patients were younger than severe or critical patients. The number of patients with shortness of breath and underlying diabetes and heart disease at admission was higher in the severe or critical group. This group also showed considerably lower or higher values in 28 laboratory indicators. In addition, mild and moderate patients who remained stable were younger than moderate patients progressing to severe disease. Men had a higher risk of disease progression. Patients who progressed had either higher or lower values in 11 laboratory indicators. Survival curve analysis showed that age, procalcitonin, D-dimer, serum C-reactive protein, lactate dehydrogenase, lymphocytes, neutrophils, CD4%, and CD4/CD8 ratio were significant predictors of progression to severe disease. Conclusions: Lactate dehydrogenase, procalcitonin, etc. are early warning indicators of severe COVID-19. Age (>64 years), shortness of breath, past histories of diabetes and heart disease, and abnormality in 28 other indicators at admission are indicative of severe or progression toward severe COVID-19. Meanwhile, abnormalities in 11 indicators and an abnormal coagulation function index at admission are risk factors for progression to severe disease.

Lactate Dehydrogenase and Susceptibility to Deterioration of Mild COVID-19 Patients: a Multicenter Nested Case-Control Study

Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis

Proteomic and Metabolomic Investigation of Serum Lactate Dehydrogenase Elevation in COVID‐19 Patients

LDH and NLR, as inflammatory markers, the independent risk factors for COVID-19 complicated with respiratory failure in elderly patients

Serum Lactate Dehydrogenase Level as a Prognostic Factor for COVID-19: A Retrospective Study Based on a Large Sample Size

Abnormal liver function on admission predicts severe outcomes in COVID-19 patients: a multicenter study (Preprint)

Host susceptibility to severe COVID-19: a retrospective analysis of 487 case outside Wuhan

The Application of Lactate Dehydrogenase in Coronavirus Disease 2019 As the Best Indicator for the Progression and Clinical Status: A Case-Control Study

Predictors of COVID-19 Infection: A Prevalence Study of Hospitalized Patients

Early Warning Indicators of Severe COVID-19: A Single-Center Study of Cases From Shanghai, China

Impact of serum lactate dehydrogenase on the short-term prognosis of COVID-19 with pre-existing cardiovascular diseases

Risk factors and clinical features of deterioration in COVID-19 patients in Zhejiang, China: a single-centre, retrospective study

Implications of LDH in patients with coronavirus disease 2019 pneumonia

Laboratory Testing Implications of Risk-Stratification and Management for Improving Clinical Outcomes of COVID-19 Patients

Dynamic Changes in Liver Function Tests and Their Correlation with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study

Early predictive factors of progression from severe type to critical ill type in patients with Coronavirus Disease 2019: A retrospective cohort study

Lysosome activation in peripheral blood mononuclear cells and prognostic significance of circulating LC3B in COVID-19

Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan

Prognostic value of elevated lactate dehydrogenase in patients with COVID-19: a systematic review and meta-analysis

Clinical Characteristics of Chronic Liver Disease with Coronavirus Disease 2019 (COVID-19): a Cohort Study in Wuhan, China